Koichi Okamoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Koichi Okamoto has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Noriyuki Inaki
Department of Gastrointestinal Surgery, Kanazawa University, Kanazawa, Japan
9 shared publications- Noriyuki Inaki
Department of Gastrointestinal Surgery, Kanazawa University Hospital, Kanazawa, Japan
9 shared publications - Hiroyuki Takamura
Department of Surgical Oncology, Kanazawa Medical University, Daigaku, Uchinadamachi, Kahoku 920-0293, Japan
7 shared publications Itasu Ninomiya
Department of Surgery, Fukui Prefectural Hospital, Fukui, Japan
7 shared publications- Jun Kinoshita
Department of Gastrointestinal Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan
7 shared publications Keishi Nakamura
Department of Gastrointestinal Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920‑8641, Japan
7 shared publications
Latest Publications
- Open Access
Current Status and Challenges of Local Resection for Early Gastric Cancer in East Asia
Background/Objectives: Standard gastrectomy with lymph node dissection up to D1+ achieves good oncologic control for early gastric cancer not amenable to endoscopic submucosal dissection, yet it frequently leads to post-gastrectomy syndromes and long-term nutritional impairment. Local resection of the stomach reduces post-gastrectomy syndrome; however, the extent of lymph node dissection should be limited beyond D1+ in such cases. This review evaluates the safety of local resection for early gastric cancer reported in East Asia. Methods: We reviewed current concepts and clinical evidence regarding (i) the limitations of preoperative nodal staging, (ii) sentinel node biopsy and function-preserving gastrectomy, and (iii) functional outcomes and procedure-specific complications following local resection, with a focus on delayed gastric emptying. Results: Conventional imaging and biomarkers are inadequate for reliable preoperative identification of node-negative disease. Conversely, sentinel node biopsies demonstrate high intraoperative diagnostic accuracy. Large prospective studies have revealed that, when indications are strictly adhered to, sentinel node biopsy-guided function-preserving gastrectomy can yield survival outcomes comparable to those of standard gastrectomy. The indications for local resection include solitary submucosal tumors below 4 cm in size, diagnosed as node-negative by sentinel node biopsy. Although the available quality-of-life data are generally favorable, there is risk of delayed gastric emptying in local resection with limited lymph node dissection in cases of early gastric cancer. Postoperative gastric deformity following closure was identified as the primary cause. Conclusions: Local resection for submucosal gastric cancer guided by sentinel node biopsy may be oncologically acceptable and function-preserving; however, the prevention of gastric deformity is crucial for its safe implementation.
Open AccessCurrent Status and Challenges of Local Resection for Early Gastric Cancer in East Asia
Background/Objectives: Standard gastrectomy with lymph node dissection up to D1+ achieves good oncologic control for early gastric cancer not amenable to endoscopic submucosal dissection, yet it frequently leads to post-gastrectomy syndromes and long-term nutritional impairment. Local resection of the stomach reduces post-gastrectomy syndrome; however, the extent of lymph node dissection should be limited beyond D1+ in such cases. This review evaluates the safety of local resection for early gastric cancer reported in East Asia. Methods: We reviewed current concepts and clinical evidence regarding (i) the limitations of preoperative nodal staging, (ii) sentinel node biopsy and function-preserving gastrectomy, and (iii) functional outcomes and procedure-specific complications following local resection, with a focus on delayed gastric emptying. Results: Conventional imaging and biomarkers are inadequate for reliable preoperative identification of node-negative disease. Conversely, sentinel node biopsies demonstrate high intraoperative diagnostic accuracy. Large prospective studies have revealed that, when indications are strictly adhered to, sentinel node biopsy-guided function-preserving gastrectomy can yield survival outcomes comparable to those of standard gastrectomy. The indications for local resection include solitary submucosal tumors below 4 cm in size, diagnosed as node-negative by sentinel node biopsy. Although the available quality-of-life data are generally favorable, there is risk of delayed gastric emptying in local resection with limited lymph node dissection in cases of early gastric cancer. Postoperative gastric deformity following closure was identified as the primary cause. Conclusions: Local resection for submucosal gastric cancer guided by sentinel node biopsy may be oncologically acceptable and function-preserving; however, the prevention of gastric deformity is crucial for its safe implementation.
- Open Access
Two-Dimensional CT Tumor Measurement Predicts Pathological Response and Prognosis After Neoadjuvant DCF Therapy in Esophageal Squamous Cell Carcinoma
Background/Objective: Evaluating the response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma (ESCC) is challenging because primary tumors are often classified as non-measurable under the RECIST criteria. This study investigated whether two-dimensional computed tomography (CT) measurements predict pathological response and prognosis after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy in ESCC. Methods: We retrospectively analyzed 123 patients who underwent radical esophagectomy following DCF therapy at two institutions (April 2011–March 2024). Changes in the short-axis, long-axis, and short-axis × long-axis diameters of the primary tumor after preoperative chemotherapy were measured on contrast-enhanced CT, and the reduction rate for each parameter was assessed. Based on the optimal cutoff values, univariate and multivariate analyses were conducted to identify significant predictors of pathological response. Results: The short-axis × long-axis diameter reduction rate (SLRR) demonstrated the highest area under the curve (0.901), with a cutoff value of 0.55 for predicting pathological response, and it was the only independent predictor in the multivariate analysis (odds ratio, 6.27; p = 0.048). In group comparisons using the SLRR cutoff value, patients with a high SLRR had significantly better 3-year recurrence-free survival (67.8% vs. 29.4%, p < 0.001) and overall survival (79.5% vs. 46.6%, p < 0.001) than those with a low SLRR. Conclusions: The CT-based SLRR independently predicts both pathological response and prognosis after neoadjuvant DCF therapy in ESCC.
Open AccessTwo-Dimensional CT Tumor Measurement Predicts Pathological Response and Prognosis After Neoadjuvant DCF Therapy in Esophageal Squamous Cell Carcinoma
Background/Objective: Evaluating the response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma (ESCC) is challenging because primary tumors are often classified as non-measurable under the RECIST criteria. This study investigated whether two-dimensional computed tomography (CT) measurements predict pathological response and prognosis after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy in ESCC. Methods: We retrospectively analyzed 123 patients who underwent radical esophagectomy following DCF therapy at two institutions (April 2011–March 2024). Changes in the short-axis, long-axis, and short-axis × long-axis diameters of the primary tumor after preoperative chemotherapy were measured on contrast-enhanced CT, and the reduction rate for each parameter was assessed. Based on the optimal cutoff values, univariate and multivariate analyses were conducted to identify significant predictors of pathological response. Results: The short-axis × long-axis diameter reduction rate (SLRR) demonstrated the highest area under the curve (0.901), with a cutoff value of 0.55 for predicting pathological response, and it was the only independent predictor in the multivariate analysis (odds ratio, 6.27; p = 0.048). In group comparisons using the SLRR cutoff value, patients with a high SLRR had significantly better 3-year recurrence-free survival (67.8% vs. 29.4%, p < 0.001) and overall survival (79.5% vs. 46.6%, p < 0.001) than those with a low SLRR. Conclusions: The CT-based SLRR independently predicts both pathological response and prognosis after neoadjuvant DCF therapy in ESCC.
- Open Access
- 19 May 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Characteristic pathological findings of achalasia behind unresectable esophageal cancer with pathological complete response after chemotherapy: a case report and literature review
Esophageal achalasia is a rare disease characterized by impaired peristalsis throughout the esophagus, marked esophageal dilation, and nonorganic stenosis
- 19 May 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Open AccessCharacteristic pathological findings of achalasia behind unresectable esophageal cancer with pathological complete response after chemotherapy: a case report and literature review
Esophageal achalasia is a rare disease characterized by impaired peristalsis throughout the esophagus, marked esophageal dilation, and nonorganic stenosis
- 10 March 2026
- Published by Wiley in Microscopy Research and Technique
- Vol. 89 (8) , 1095-1110
Accuracy of Automatic Quantitative Analysis of Pathological Tissue Images Using ChatGPT Data Analyst: Comparison With Semi‐Automated Analysis in an MC38 Mouse Liver Metastasis Model
Colorectal cancer has a high incidence and mortality rate worldwide. In advanced cases, liver metastasis frequently occurs and determines the prognosis. Image analysis of pathological tissues from organs with metastasis is essential for tumor research and diagnosis, but relies on manual or semi‐automated software processing, challenging user expertise, and efficiency. We evaluated the image analysis capabilities of ChatGPT (Data Analyst) to automatically quantify tumor regions in H&E‐stained sections from a mouse metastasis model established using MC38 cells. Using ChatGPT Data Analyst, we analyzed the tumor area, total liver area, tumor proportion, and tumor count and compared the results with those obtained using conventional ImageJ analysis. Area measurements showed a high correlation ( r > 0.99) and agreement (ICC > 0.9) between the ChatGPT Data Analyst and ImageJ, with high reproducibility upon reanalysis. Given that the clarity of the boundary between the tumor and liver parenchyma is influenced by staining conditions, we investigated optimal protocols and identified specific conditions (hematoxylin for 2 min, eosin for 30 s) that are crucial for enhancing extraction accuracy. Furthermore, comprehensive benchmarking revealed that advanced general‐purpose LLMs (GPT‐5.1 and Gemini‐2.5 Pro) achieved accuracy comparable to that of a specialized AI framework (SAM + PLIP) and commercial software (NIS‐Elements AR). ChatGPT Data Analyst offers a novel method for pathological image analysis based on prompt instructions, with an accuracy comparable to that of conventional methods. Future improvements in tumor count detection through ChatGPT Data Analyst updates and standardized staining conditions will enhance its application in pathological research and diagnosis of tumors.
- 10 March 2026
- Published by Wiley in Microscopy Research and Technique
- Vol. 89 (8) , 1095-1110
Accuracy of Automatic Quantitative Analysis of Pathological Tissue Images Using ChatGPT Data Analyst: Comparison With Semi‐Automated Analysis in an MC38 Mouse Liver Metastasis Model
Colorectal cancer has a high incidence and mortality rate worldwide. In advanced cases, liver metastasis frequently occurs and determines the prognosis. Image analysis of pathological tissues from organs with metastasis is essential for tumor research and diagnosis, but relies on manual or semi‐automated software processing, challenging user expertise, and efficiency. We evaluated the image analysis capabilities of ChatGPT (Data Analyst) to automatically quantify tumor regions in H&E‐stained sections from a mouse metastasis model established using MC38 cells. Using ChatGPT Data Analyst, we analyzed the tumor area, total liver area, tumor proportion, and tumor count and compared the results with those obtained using conventional ImageJ analysis. Area measurements showed a high correlation ( r > 0.99) and agreement (ICC > 0.9) between the ChatGPT Data Analyst and ImageJ, with high reproducibility upon reanalysis. Given that the clarity of the boundary between the tumor and liver parenchyma is influenced by staining conditions, we investigated optimal protocols and identified specific conditions (hematoxylin for 2 min, eosin for 30 s) that are crucial for enhancing extraction accuracy. Furthermore, comprehensive benchmarking revealed that advanced general‐purpose LLMs (GPT‐5.1 and Gemini‐2.5 Pro) achieved accuracy comparable to that of a specialized AI framework (SAM + PLIP) and commercial software (NIS‐Elements AR). ChatGPT Data Analyst offers a novel method for pathological image analysis based on prompt instructions, with an accuracy comparable to that of conventional methods. Future improvements in tumor count detection through ChatGPT Data Analyst updates and standardized staining conditions will enhance its application in pathological research and diagnosis of tumors.
- Open Access
Current Status and Future Applications of Robotic Surgery in Upper Gastrointestinal Surgery: A Narrative Review
Robot-assisted surgery has proven highly effective in the curative treatment of various gastrointestinal cancers. The advantages of robot-assisted surgery, including precision, enhanced operability, and magnified 3D visualization, allow surgeons to perform delicate procedures that would be challenging with conventional laparotomy or laparoscopy. These benefits make robot-assisted surgery a viable modality for treating various malignant tumors and an essential tool in curative surgery for solid cancers. Laparoscopic gastrectomy is currently the standard treatment for early gastric cancer, with numerous clinical trials assessing the efficacy of robot-assisted surgery. Although thoracoscopic esophagectomy has demonstrated advantages over open surgery in radical esophageal cancer treatment, ongoing studies are evaluating the noninferiority and potential benefits of robotic surgery. Robot-assisted surgery is also being explored for conversion surgery in cases where radical resection becomes feasible after multidisciplinary treatment and in polysurgery cases involving multiple prior laparotomies. However, establishing robust evidence for its efficacy in radical surgery for conversion and polysurgery cases remains a challenge. This narrative review discusses the advantages and limitations of robot-assisted surgery in such complex cases based on an analysis of the literature. Additionally, it examines the prospects of robotic-assisted surgery in polysurgery, metachronous remnant gastric cancer, and conversion surgery.
Open AccessCurrent Status and Future Applications of Robotic Surgery in Upper Gastrointestinal Surgery: A Narrative Review
Robot-assisted surgery has proven highly effective in the curative treatment of various gastrointestinal cancers. The advantages of robot-assisted surgery, including precision, enhanced operability, and magnified 3D visualization, allow surgeons to perform delicate procedures that would be challenging with conventional laparotomy or laparoscopy. These benefits make robot-assisted surgery a viable modality for treating various malignant tumors and an essential tool in curative surgery for solid cancers. Laparoscopic gastrectomy is currently the standard treatment for early gastric cancer, with numerous clinical trials assessing the efficacy of robot-assisted surgery. Although thoracoscopic esophagectomy has demonstrated advantages over open surgery in radical esophageal cancer treatment, ongoing studies are evaluating the noninferiority and potential benefits of robotic surgery. Robot-assisted surgery is also being explored for conversion surgery in cases where radical resection becomes feasible after multidisciplinary treatment and in polysurgery cases involving multiple prior laparotomies. However, establishing robust evidence for its efficacy in radical surgery for conversion and polysurgery cases remains a challenge. This narrative review discusses the advantages and limitations of robot-assisted surgery in such complex cases based on an analysis of the literature. Additionally, it examines the prospects of robotic-assisted surgery in polysurgery, metachronous remnant gastric cancer, and conversion surgery.
- Open Access
- 12 May 2025
- Published by Spandidos Publications in Oncology Letters
- Vol. 30 (1) , 1-10
Successful robot‑assisted minimally invasive surgery for scirrhous gastric conduit cancer after esophagectomy: A case report
Patients with reconstructed gastric conduit cancer following esophageal cancer surgery can be treated through gastric conduit resection and regional lymph node dissection for pathological R0 resection. However, these procedures are difficult owing to the adhesions and scars around the gastric conduit and anatomical irregularities. To the best of our knowledge, robotic resection for scirrhous gastric conduit cancer occurring along almost the entire reconstructed gastric conduit has not been reported in the literature to date. The present study report the case of a 69‑year‑old man who underwent radical robot‑assisted surgery for advanced gastric conduit cancer along most of the gastric conduit with regional lymph node metastases. The patient had previously undergone robot‑assisted thoracoscopic esophagectomy and posterior mediastinal gastric conduit reconstruction for thoracic esophageal cancer at another hospital. Subsequently, 5 years later, the patient underwent esophagogastroduodenoscopy for a passage disorder, during which an elevated lesion with severe stenosis was found at the esophagogastric anastomosis, along with mucosal irregularity along the reconstructed gastric conduit that was then pathologically diagnosed as poorly differentiated adenocarcinoma. Thereafter, the patient was referred to Kanazawa Medical University Hospital (Kahoku, Japan) where he underwent robotic intrathoracic surgery. Forceps manipulations under a three‑dimensional magnified view were conducted to dissect the adhesions around the lung, chest wall, tracheal membranous portion and reconstructed gastric conduit. Curative total remnant gastrectomy with lymph node dissection and digestive‑tract reconstruction using a pedicled jejunum were conducted without severe intraoperative injuries. Pathological analysis of the resected specimen indicated scirrhous gastric conduit cancer originating along the gastric conduit with marked full‑thickness fibrosis and clusters of adenocarcinoma cells. No obvious cancer remnants were found on the dissected surface of the subserous layer of the gastric conduit. After postoperative adjuvant chemotherapy with oral tegafur/gimeracil/oteracil and intravenous docetaxel for 4 months, the patient was alive without recurrence at 9 months postoperatively.
- 12 May 2025
- Published by Spandidos Publications in Oncology Letters
- Vol. 30 (1) , 1-10
Open AccessSuccessful robot‑assisted minimally invasive surgery for scirrhous gastric conduit cancer after esophagectomy: A case report
Patients with reconstructed gastric conduit cancer following esophageal cancer surgery can be treated through gastric conduit resection and regional lymph node dissection for pathological R0 resection. However, these procedures are difficult owing to the adhesions and scars around the gastric conduit and anatomical irregularities. To the best of our knowledge, robotic resection for scirrhous gastric conduit cancer occurring along almost the entire reconstructed gastric conduit has not been reported in the literature to date. The present study report the case of a 69‑year‑old man who underwent radical robot‑assisted surgery for advanced gastric conduit cancer along most of the gastric conduit with regional lymph node metastases. The patient had previously undergone robot‑assisted thoracoscopic esophagectomy and posterior mediastinal gastric conduit reconstruction for thoracic esophageal cancer at another hospital. Subsequently, 5 years later, the patient underwent esophagogastroduodenoscopy for a passage disorder, during which an elevated lesion with severe stenosis was found at the esophagogastric anastomosis, along with mucosal irregularity along the reconstructed gastric conduit that was then pathologically diagnosed as poorly differentiated adenocarcinoma. Thereafter, the patient was referred to Kanazawa Medical University Hospital (Kahoku, Japan) where he underwent robotic intrathoracic surgery. Forceps manipulations under a three‑dimensional magnified view were conducted to dissect the adhesions around the lung, chest wall, tracheal membranous portion and reconstructed gastric conduit. Curative total remnant gastrectomy with lymph node dissection and digestive‑tract reconstruction using a pedicled jejunum were conducted without severe intraoperative injuries. Pathological analysis of the resected specimen indicated scirrhous gastric conduit cancer originating along the gastric conduit with marked full‑thickness fibrosis and clusters of adenocarcinoma cells. No obvious cancer remnants were found on the dissected surface of the subserous layer of the gastric conduit. After postoperative adjuvant chemotherapy with oral tegafur/gimeracil/oteracil and intravenous docetaxel for 4 months, the patient was alive without recurrence at 9 months postoperatively.
- 28 April 2025
- Published by Springer Nature in Esophagus
- Vol. 22 (3) , 390-397
Fistula closure technique using an esophageal stent and fixation method for gastrointestinal-airway fistula after esophageal cancer surgery
Background The occurrence of a gastrointestinal-airway fistula after esophageal cancer surgery is a serious and fatal complication that can cause severe respiratory complications. It is a pathological condition requiring prompt intervention to avoid a fatal course. Conventionally, highly invasive surgical treatment has been selected for the treatment for gastrointestinal-airway fistula, but its difficulty and mortality risk cannot be neglected. Esophageal stent placement is useful as a nonoperative management for gastrointestinal-airway fistulas, but the success rate of fistula closure is not that high. Hence, an effective method that can solve technical problems to avoid intervention-related complications and increases the success rate of fistula closure by stent placement needs to be developed. We have achieved better results with our unique ingenuity for the management of esophageal stent placement; thus, we aimed to describe the details of the management methods. Methods Our technique used in stent placement included endoscopic insertion of the self-expandable metallic stent and the fixation of the stent with a nylon thread and a transnasal catheter on the face. With this ingenuity, it becomes possible to reduce stent migration, and an easy and quick adjustment of its position in case of stent migration can be possible. Results We have experienced successfully cured cases with our novel technique [five of seven cases (71.4%)] with a minimum indwelling period. Conclusions Our technique is feasible for use in the management of gastrointestinal-airway fistula after esophageal cancer surgery.
- 28 April 2025
- Published by Springer Nature in Esophagus
- Vol. 22 (3) , 390-397
Fistula closure technique using an esophageal stent and fixation method for gastrointestinal-airway fistula after esophageal cancer surgery
Background The occurrence of a gastrointestinal-airway fistula after esophageal cancer surgery is a serious and fatal complication that can cause severe respiratory complications. It is a pathological condition requiring prompt intervention to avoid a fatal course. Conventionally, highly invasive surgical treatment has been selected for the treatment for gastrointestinal-airway fistula, but its difficulty and mortality risk cannot be neglected. Esophageal stent placement is useful as a nonoperative management for gastrointestinal-airway fistulas, but the success rate of fistula closure is not that high. Hence, an effective method that can solve technical problems to avoid intervention-related complications and increases the success rate of fistula closure by stent placement needs to be developed. We have achieved better results with our unique ingenuity for the management of esophageal stent placement; thus, we aimed to describe the details of the management methods. Methods Our technique used in stent placement included endoscopic insertion of the self-expandable metallic stent and the fixation of the stent with a nylon thread and a transnasal catheter on the face. With this ingenuity, it becomes possible to reduce stent migration, and an easy and quick adjustment of its position in case of stent migration can be possible. Results We have experienced successfully cured cases with our novel technique [five of seven cases (71.4%)] with a minimum indwelling period. Conclusions Our technique is feasible for use in the management of gastrointestinal-airway fistula after esophageal cancer surgery.
- Open Access
- 2 August 2024
- Published by Spandidos Publications in Oncology Reports
- Vol. 52 (4) , 1-12
Metformin suppresses esophageal cancer progression through the radiation‑induced cellular senescence of cancer‑associated fibroblasts
Senescent cells are known to secrete proteins, including inflammatory cytokines and damage‑associated molecular patterns. This phenomenon is known as the senescence‑associated secretory phenotype (SASP). SASP in cancer stromal fibroblasts is involved in cancer growth and progression. Conversely, metformin, an antidiabetic drug, has been reported to inhibit SASP induction by inhibiting the activation of NF‑κB, a regulator of SASP. To date, at least to the best of our knowledge, there have been no reports regarding cellular senescence in fibroblasts and tumor progression via the SASP‑mediated paracrine pathway. The present study thus aimed to elucidate the induction mechanisms of SASP in radiation‑induced fibroblasts and to determine its effects on cancer progression via the paracrine pathway. Furthermore, the present study aimed to determine whether controlling SASP using metformin suppresses cancer progression. A well‑differentiated esophageal cancer cell line established by the authors' department and fibroblasts isolated and cultured from the non‑cancerous esophageal mucosa of resected esophageal cancer cases were used for the experiments. Fibroblasts were irradiated with 8 Gy radiation, and the changes in the expression of the senescence markers, SA‑β‑gal, p21, p16 and NF‑κB were evaluated using immunofluorescent staining and western blot analysis in the presence or absence of metformin treatment. The culture supernatants of irradiated fibroblasts treated with metformin and those treated without metformin were collected and added to the cancer cells to evaluate their proliferative, invasive and migratory abilities. Vimentin and E‑cadherin expression levels were also evaluated using immunofluorescent staining and western blot analysis. The expression levels of p16, p21 and NF‑κB in irradiated fibroblasts were attenuated by treatment with metformin. Supernatants collected from irradiated fibroblasts exhibited the proliferative activity of esophageal cancer cells, and the promotion of migratory and invasion abilities, which may be due to epithelial‑mesenchymal transition and changes in cell morphology. These reactions were confirmed to be suppressed by the addition of the supernatant of cultured fibroblasts pre‑treated with metformin. On the whole, the present study demonstrates that fibroblasts in the cancer stroma may be involved in tumor progression through cellular senescence.
- 2 August 2024
- Published by Spandidos Publications in Oncology Reports
- Vol. 52 (4) , 1-12
Open AccessMetformin suppresses esophageal cancer progression through the radiation‑induced cellular senescence of cancer‑associated fibroblasts
Senescent cells are known to secrete proteins, including inflammatory cytokines and damage‑associated molecular patterns. This phenomenon is known as the senescence‑associated secretory phenotype (SASP). SASP in cancer stromal fibroblasts is involved in cancer growth and progression. Conversely, metformin, an antidiabetic drug, has been reported to inhibit SASP induction by inhibiting the activation of NF‑κB, a regulator of SASP. To date, at least to the best of our knowledge, there have been no reports regarding cellular senescence in fibroblasts and tumor progression via the SASP‑mediated paracrine pathway. The present study thus aimed to elucidate the induction mechanisms of SASP in radiation‑induced fibroblasts and to determine its effects on cancer progression via the paracrine pathway. Furthermore, the present study aimed to determine whether controlling SASP using metformin suppresses cancer progression. A well‑differentiated esophageal cancer cell line established by the authors' department and fibroblasts isolated and cultured from the non‑cancerous esophageal mucosa of resected esophageal cancer cases were used for the experiments. Fibroblasts were irradiated with 8 Gy radiation, and the changes in the expression of the senescence markers, SA‑β‑gal, p21, p16 and NF‑κB were evaluated using immunofluorescent staining and western blot analysis in the presence or absence of metformin treatment. The culture supernatants of irradiated fibroblasts treated with metformin and those treated without metformin were collected and added to the cancer cells to evaluate their proliferative, invasive and migratory abilities. Vimentin and E‑cadherin expression levels were also evaluated using immunofluorescent staining and western blot analysis. The expression levels of p16, p21 and NF‑κB in irradiated fibroblasts were attenuated by treatment with metformin. Supernatants collected from irradiated fibroblasts exhibited the proliferative activity of esophageal cancer cells, and the promotion of migratory and invasion abilities, which may be due to epithelial‑mesenchymal transition and changes in cell morphology. These reactions were confirmed to be suppressed by the addition of the supernatant of cultured fibroblasts pre‑treated with metformin. On the whole, the present study demonstrates that fibroblasts in the cancer stroma may be involved in tumor progression through cellular senescence.
- Open Access
- 11 July 2024
- Published by MDPI AG in Surgical Techniques Development
- Vol. 13 (3) , 245-250
Simultaneous Laparoscopic Surgery for Esophageal Achalasia Combined with Epiphrenic Diverticulum: A Case Report
We report a case in which a 74-year-old man suffering from esophageal achalasia complicated with epiphrenic esophageal diverticulum was successfully treated with a simultaneous laparoscopic surgery. The gentleman was referred with symptoms suggestive of a passage disorder in the lower esophagus for the past 5 years. Esophagogastroduodenoscopy demonstrated an epiphrenic diverticulum at the left wall of the lower esophagus, and esophagography led to the suspicion of a combined esophageal achalasia. A simultaneous laparoscopic surgery with an abdominal approach was performed in which, following the opening of the esophageal hiatus, the diverticular wall was separated from the mediastinal organs and diverticulectomy was performed with linear staplers. After Heller’s myotomy, Dor’s fundoplication was subsequently performed in which both the incisional line of muscle layer and the suturing line of diverticulectomy were wrapped by the fornix of the stomach to make up for the wall strength and avoid the suture leakage. It was theoretically considered logical and effective to reinforce this vulnerable site with Dor’s fundoplication. He had an uneventful recovery and a rapid relief from symptoms following surgery.
- 11 July 2024
- Published by MDPI AG in Surgical Techniques Development
- Vol. 13 (3) , 245-250
Open AccessSimultaneous Laparoscopic Surgery for Esophageal Achalasia Combined with Epiphrenic Diverticulum: A Case Report
We report a case in which a 74-year-old man suffering from esophageal achalasia complicated with epiphrenic esophageal diverticulum was successfully treated with a simultaneous laparoscopic surgery. The gentleman was referred with symptoms suggestive of a passage disorder in the lower esophagus for the past 5 years. Esophagogastroduodenoscopy demonstrated an epiphrenic diverticulum at the left wall of the lower esophagus, and esophagography led to the suspicion of a combined esophageal achalasia. A simultaneous laparoscopic surgery with an abdominal approach was performed in which, following the opening of the esophageal hiatus, the diverticular wall was separated from the mediastinal organs and diverticulectomy was performed with linear staplers. After Heller’s myotomy, Dor’s fundoplication was subsequently performed in which both the incisional line of muscle layer and the suturing line of diverticulectomy were wrapped by the fornix of the stomach to make up for the wall strength and avoid the suture leakage. It was theoretically considered logical and effective to reinforce this vulnerable site with Dor’s fundoplication. He had an uneventful recovery and a rapid relief from symptoms following surgery.
- Open Access
Usefulness of Perioperative Nutritional Therapy with the Glutamine/Arginine/Calcium β-Hydroxy-β-Methylbutyrate Product in Esophageal Cancer Surgery: A Single-Center Retrospective Study
A useful perioperative nutritional therapy for highly invasive esophageal cancer surgical cases needs to be developed. We clarified the usefulness of amino-acid-enriched nutritional therapy using glutamine (Gln)/arginine (Arg)/calcium β-hydroxy-β-methylbutyrate (HMB) products on the short-term postoperative outcomes of minimally invasive esophagectomy for esophageal cancer. Altogether, 114 patients (Gln/Arg/HMB group) received perioperative nutritional therapy with Gln/Arg/HMB products, and we retrospectively investigated the change in nutritional parameters including skeletal muscle mass, occurrence of postoperative complications, and short-term postoperative outcomes in this group. The results were compared between the Gln/Arg/HMB and control groups (79 patients not receiving the Gln/Arg/HMB products). The incidence of all postoperative complications, sputum expectoration disorder, and pleural effusion of grade ≥ III was significantly lower in the Gln/Arg/HMB group (62.0% vs. 38.6%, p = 0.001; 44.3% vs. 28.1%, p = 0.020; 27.8% vs. 13.2%, p = 0.011, respectively). The psoas muscle area and postoperative body weight were significantly higher at 1 month and 1 year after surgery in the Gln/Arg/HMB group than in the control group (93.5% vs. 99.9%, p < 0.001; 92.0% vs. 95.4%, p = 0.006). Perioperative amino-acid-enriched nutritional therapy may improve the short-term postoperative outcomes, nutritional status, and skeletal muscle mass of esophageal cancer surgical patients.
Open AccessUsefulness of Perioperative Nutritional Therapy with the Glutamine/Arginine/Calcium β-Hydroxy-β-Methylbutyrate Product in Esophageal Cancer Surgery: A Single-Center Retrospective Study
A useful perioperative nutritional therapy for highly invasive esophageal cancer surgical cases needs to be developed. We clarified the usefulness of amino-acid-enriched nutritional therapy using glutamine (Gln)/arginine (Arg)/calcium β-hydroxy-β-methylbutyrate (HMB) products on the short-term postoperative outcomes of minimally invasive esophagectomy for esophageal cancer. Altogether, 114 patients (Gln/Arg/HMB group) received perioperative nutritional therapy with Gln/Arg/HMB products, and we retrospectively investigated the change in nutritional parameters including skeletal muscle mass, occurrence of postoperative complications, and short-term postoperative outcomes in this group. The results were compared between the Gln/Arg/HMB and control groups (79 patients not receiving the Gln/Arg/HMB products). The incidence of all postoperative complications, sputum expectoration disorder, and pleural effusion of grade ≥ III was significantly lower in the Gln/Arg/HMB group (62.0% vs. 38.6%, p = 0.001; 44.3% vs. 28.1%, p = 0.020; 27.8% vs. 13.2%, p = 0.011, respectively). The psoas muscle area and postoperative body weight were significantly higher at 1 month and 1 year after surgery in the Gln/Arg/HMB group than in the control group (93.5% vs. 99.9%, p < 0.001; 92.0% vs. 95.4%, p = 0.006). Perioperative amino-acid-enriched nutritional therapy may improve the short-term postoperative outcomes, nutritional status, and skeletal muscle mass of esophageal cancer surgical patients.